Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210086) titled 'Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210203) titled 'Additional Effects of Neural Mobilization on Pain, Balance and Quality of Life... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210242) titled 'HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210281) titled 'Osteogenon in Orthopedics and Traumatology' on Sept. 29. Study Type: Interven... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210320) titled 'PK/PD Study of IN-001 Sublingual Spray in Healthy Adults' on Sept. 29. Study ... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210359) titled 'Evaluation of Regenerative Endodontic Treatment for Immature Teeth' on Sept. 2... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210398) titled 'Mindfulness-based Cognitive Therapy for the Chronic Pain-early Cognitive Decli... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210437) titled 'Longitudinal Autonomic Characterization as a Predictor for Secondary Medical C... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210593) titled 'STrong Relationships to Improve DiabEtes Pilot' on Sept. 29. Study Type: Inte... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210632) titled 'Window Trial of Fluorescently Labeled Nivolumab (Nivo800) in High Grade Glioma... Read More